More News! 21 Jan 2019 Danish Biotech Turns Bacteria into Fermentation Workaholics The Danish biotech Enduro Genetics has shown it can improve the yield of fermentation by engineering bacteria to become ‘addicted’ to being productive. Fermentation vats full of bacteria or yeast are the workhorses for industries such as the pharmaceutical and chemical industry. They are used to mass-produce products including detergents, drugs and biofuels. The cells […] January 21, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 14 Jan 2019 Inhaled Lung Disease Treatment Encounters Mixed Results in Phase II Trial An inhaled drug from British company Verona Pharma has failed to significantly improve lung function in patients with the lung disease chronic obstructive pulmonary disease, though it did produce some benefits. The 79 patients in the phase II trial suffered from chronic obstructive pulmonary disease, a condition where inflammation in the lungs restricts the airways […] January 14, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 20 Dec 2018 Cambridge Company Raises €20M for Potential First in Lung Disease Morphogen-IX, based in Cambridge, has raised €20.4M (£18.4M) to fund a new type of treatments for pulmonary arterial hypertension. The Series B financing will go towards the preclinical development of the company’s lead candidate, which has the potential to become the first to treat the condition rather than just addressing the symptoms. People with pulmonary […] December 20, 2018 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 14 Dec 2018 Cultured Meat Company Offers a Taste of the First Lab-Grown Steak The Israeli company Aleph Farms has shared with the world the first prototype of a beef steak that has been grown in a lab, harming no animal in the process. Although the world’s first lab-grown burger was tasted in 2013, growing a steak had so far remained a challenge. “We are the first company that […] December 14, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2018 British Company Raises €37M to Personalize Therapies with Machine Learning Genomics, a company based in Oxford, has increased the amount raised in a Series B round that will fund further development of its genomics technology for personalized medicine. The company adds a further €9M (£8M) to the round with the participation of Foresite Capital and F-Prime Capital, two renowned US life sciences investors. The previous […] December 10, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 29 Nov 2018 Long-Lasting Placenta Organoids Could Improve Pregnancy Research Researchers have made 3D placenta organoids from human cells that can last for over a year, improving over the current models to study disease in pregnancy and develop drugs. Researchers at the University of Cambridge grew the organoids from stem cells extracted from donated placenta tissue at 6-9 weeks of pregnancy. The organoids replicated the […] November 29, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 22 Nov 2018 First Drug for Rare Inflammation Syndrome Approved by FDA The FDA has approved the first drug for the treatment of a rare condition in which the body produces too many active immune cells, developed in a Swiss-Swedish partnership. The antibody drug, emapalumab, is approved to treat primary hemophagocytic lymphohistiocytosis. This condition is a rare, often fatal syndrome in which the immune system produces too […] November 22, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 20 Nov 2018 Phase I Gives Hope for First Zika Vaccine Results from a Phase I trial showed promising safety and efficacy of a potential first vaccine against the mosquito-borne Zika virus, developed by French biotech Valneva and US biopharma Emergent BioSolutions. In the US-based Phase I trial, 67 participants were injected with either placebo or inactivated forms of the virus as a vaccine. Two months later, […] November 20, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 19 Nov 2018 Anti-Inflammatory Treatments Get €40M Boost in Series B A Series B funding round has whipped up €40M for the Irish company Inflazome. This money will help to fund clinical trials for anti-inflammatory treatments targeting conditions such as Alzheimer’s and Parkinson’s disease. “We are extremely excited about this opportunity, which is such a large funding round in a European company,” Marco Boorsma, General Partner […] November 19, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 16 Nov 2018 AbbVie Enters Industry Collaboration to Fight Alzheimer’s and Parkinson’s Disease The UK biotech Mission Therapeutics has teamed up with AbbVie to develop new drugs to treat the neurodegenerative conditions Alzheimer’s disease and Parkinson’s disease. The new collaboration aims to fund the preclinical development of drugs that inhibit proteins called deubiquitinating enzymes. Deubiquitinating enzymes modify proteins in the cell, controlling essential functions such as what the […] November 16, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 15 Nov 2018 Soldier Bug Could Help Combat Antibiotic Resistance A garden insect makes a molecule that attacks the cell wall of bacteria, providing a new potential weapon in the fight against antibiotic resistance. Thanatin is a peptide molecule produced by the spined soldier bug Podisus maculiventris to control the types of bacteria that live in its gut. A research group from the University of Zurich […] November 15, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 13 Nov 2018 French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins The French company Quantum Genomics is developing a first-in-class drug that targets proteins in the brain to lower blood pressure. A Phase IIb trial, run by Quantum Genomics, found that eight weeks of taking its drug significantly lowered blood pressure in patients who were overweight or obese and with high blood pressure. This reduction also […] November 13, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email